ZA200700178B - Pharmaceutical composition containing polypeptide fragments of serralysins - Google Patents

Pharmaceutical composition containing polypeptide fragments of serralysins

Info

Publication number
ZA200700178B
ZA200700178B ZA200700178A ZA200700178A ZA200700178B ZA 200700178 B ZA200700178 B ZA 200700178B ZA 200700178 A ZA200700178 A ZA 200700178A ZA 200700178 A ZA200700178 A ZA 200700178A ZA 200700178 B ZA200700178 B ZA 200700178B
Authority
ZA
South Africa
Prior art keywords
serralysins
pharmaceutical composition
composition containing
polypeptide fragments
containing polypeptide
Prior art date
Application number
ZA200700178A
Other languages
English (en)
Inventor
Abrahantes Purez Marya Carmen
Vuliz Rios Gloria
Gasmuri Gonzslez Caridad Anais
Bequet Romero Monica
Castellanos Serra Lila Rosa
Riera Raul Gomez
Gonzslez Jesus Reyes
Martynez Dyaz Eduardo
Garcya Susrez Josu
Gonzslez Lopez Luis Javier
Selman-Housein Sosa Manuel
Gavilondo Cowley Jorge Victor
Original Assignee
Ct Ingenieria Genetica Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Ingenieria Genetica Biotech filed Critical Ct Ingenieria Genetica Biotech
Publication of ZA200700178B publication Critical patent/ZA200700178B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/265—Enterobacter (G)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
ZA200700178A 2004-07-08 2007-01-05 Pharmaceutical composition containing polypeptide fragments of serralysins ZA200700178B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20040147A CU23475A1 (es) 2004-07-08 2004-07-08 Composición farmacéutica conteniendo fragmentos polipeptídicos de serralisinas

Publications (1)

Publication Number Publication Date
ZA200700178B true ZA200700178B (en) 2008-06-25

Family

ID=40259088

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200700178A ZA200700178B (en) 2004-07-08 2007-01-05 Pharmaceutical composition containing polypeptide fragments of serralysins

Country Status (22)

Country Link
US (1) US8076297B2 (xx)
EP (1) EP1787653B1 (xx)
JP (1) JP4914350B2 (xx)
KR (1) KR101365056B1 (xx)
AR (1) AR050255A1 (xx)
AU (1) AU2005262159B2 (xx)
BR (1) BRPI0513136A (xx)
CA (1) CA2572984C (xx)
CU (1) CU23475A1 (xx)
CY (1) CY1114201T1 (xx)
DK (1) DK1787653T3 (xx)
ES (1) ES2389126T3 (xx)
HR (1) HRP20120682T1 (xx)
MX (1) MX2007000339A (xx)
MY (1) MY150858A (xx)
PL (1) PL1787653T3 (xx)
PT (1) PT1787653E (xx)
RS (1) RS52448B (xx)
RU (1) RU2396274C2 (xx)
SI (1) SI1787653T1 (xx)
WO (1) WO2006005268A2 (xx)
ZA (1) ZA200700178B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006056575A1 (en) * 2004-11-23 2006-06-01 Zymogenetics, Inc. Purification of recombinant human factor xiii
EP2147327B1 (en) 2007-05-04 2018-06-20 Koninklijke Philips N.V. Combination of mr and pet with correction for radiation absorption by an mr coil
CU23950B1 (es) 2011-03-21 2013-10-29 Ct De Ingeniería Genética Y Biotecnología Péptidos cíclicos con actividad antineoplásica y antiangiogénica
TWI746449B (zh) * 2015-07-20 2021-11-21 美商Ａｉ治療公司 使用阿吡莫德治療癌症之方法
CN109295041A (zh) * 2018-10-10 2019-02-01 宁波希诺亚海洋生物科技有限公司 具有舍雷肽酶活性的多肽及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58134991A (ja) * 1981-12-28 1983-08-11 Takeda Chem Ind Ltd セラチオペプチタ−ゼの安定化法
JP2611206B2 (ja) * 1985-11-15 1997-05-21 武田薬品工業株式会社 遺伝子およびその利用方法
KR100252197B1 (ko) * 1997-09-20 2000-04-15 박호군 세라시아 마르세센스 균주의 배양액으로 부터 분리한 면역억제제용 프로디지오신
US20040185566A1 (en) * 2003-03-19 2004-09-23 Peter Salamone Polypeptides toxic to nematodes and methods of use

Also Published As

Publication number Publication date
CA2572984C (en) 2014-12-09
PT1787653E (pt) 2012-09-06
DK1787653T3 (da) 2012-09-17
SI1787653T1 (sl) 2012-10-30
EP1787653B1 (en) 2012-06-06
RS52448B (en) 2013-02-28
EP1787653A2 (en) 2007-05-23
US20110218138A1 (en) 2011-09-08
AR050255A1 (es) 2006-10-11
WO2006005268A2 (es) 2006-01-19
KR20070042542A (ko) 2007-04-23
CU23475A1 (es) 2009-12-17
MX2007000339A (es) 2007-03-12
US8076297B2 (en) 2011-12-13
RU2007104776A (ru) 2008-08-20
JP4914350B2 (ja) 2012-04-11
HRP20120682T1 (hr) 2012-09-30
MY150858A (en) 2014-03-14
JP2008505129A (ja) 2008-02-21
KR101365056B1 (ko) 2014-02-21
PL1787653T3 (pl) 2012-11-30
BRPI0513136A (pt) 2008-04-29
ES2389126T3 (es) 2012-10-23
RU2396274C2 (ru) 2010-08-10
AU2005262159B2 (en) 2011-08-18
AU2005262159A1 (en) 2006-01-19
WO2006005268A3 (es) 2006-03-09
CY1114201T1 (el) 2016-08-31
CA2572984A1 (en) 2006-01-19

Similar Documents

Publication Publication Date Title
IL177403A0 (en) Pancreatic polypeptide family polypeptides and pharmaceutical compositions containing the same
IL173930A0 (en) Pharmaceutical compositions containing forms of r-baclofen
IL178070A (en) Antibiotic p-selectin antibodies and pharmaceuticals that include them
IL177480A0 (en) Pharmaceutical composition
IL179933A0 (en) Pharmaceutical compositions containing proteosome based compositions
GB0321607D0 (en) Manufacture of pharmaceutical compositions
IL179732A0 (en) Novel use of peptide compounds for treting essential tremor and other tremor syndromes
ZA200508204B (en) Pharmaceutical composition of atorvastatin
HU0301154D0 (en) Pharmaceutical composition
GB0300427D0 (en) Pharmaceutical composition
ZA200702938B (en) Peptides and APL-type derivatives of Hsp60 and pharmaceutical compositions
GB0307866D0 (en) Pharmaceutical composition
EP1758577A4 (en) NEW COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHOD OF ADMINISTRATION THEREFOR
PL1791530T3 (pl) Kompozycja farmaceutyczna zawierająca psychostymulant
EP1699458A4 (en) PHARMACEUTICAL COMPOSITION
GB0329232D0 (en) Pharmaceutical composition
ZA200700178B (en) Pharmaceutical composition containing polypeptide fragments of serralysins
GB0317663D0 (en) Pharmaceutical composition
HU0401177D0 (en) Pharmaceutical composition
GB2411355B (en) Pharmaceutical composition
GB0300885D0 (en) Pharmaceutical composition
ZA200701932B (en) Pharmaceutical composition
GB0425255D0 (en) Pharmaceutical composition
HUP0500813A2 (en) Pharmaceutical composition containing violaceae extract
ZA200701931B (en) Pharmaceutical composition